The FDA this week approved a controversial drug to help treat depression and it the first new antidepressant to be greenlit in decades.  It is a nasal spray branded as Spravato made by Johnson and Johnson and is very similar to Ketamine. The benefit of this nasal spray is its fast acting impact on depression symptoms. Peter Loftus, reporter for the WSJ, joins us for more on this new drug.

Next, phone numbers are quickly becoming the new social security numbers.  Your mobile phone number is becoming the primary way for tech companies like Facebook to identify users and secure your accounts, think two-factor authentication.  Scott Rosenberg, technology editor at Axios, joins us for the big problem, your phone and number are being used like access keys, and how often do you want to give that information away.

Finally, R. Kelly has broken his silence on the latest sexual abuse claims against him.  In a nearly 80 minute interview he did with Gayle King from CBS, R. Kelly denies all the allegations, says everyone is lying about him and plays the victim claiming he has too big of a heart. It is an explosive interview and my producer Miranda joins us to break it all down.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.